Intravenous Immunoglobulin: An Update on the Clinical Use and Mechanisms of Action
Top Cited Papers
- 11 March 2007
- journal article
- review article
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 27 (3) , 233-245
- https://doi.org/10.1007/s10875-007-9088-9
Abstract
Initially used as a replacement therapy for immunodeficiency diseases, intravenous immunoglobulin (IVIg) is now widely used for a number of autoimmune and inflammatory diseases. Considerable progress has been made in understanding the mechanisms by which IVIg exerts immunomodulatory effects in autoimmune and inflammatory disorders. The mechanisms of action of IVIg are complex, involving modulation of expression and function of Fc receptors, interference with activation of complement and the cytokine network and of idiotype network, regulation of cell growth, and effects on the activation, differentiation, and effector functions of dendritic cells, and T and B cells.Keywords
This publication has 149 references indexed in Scilit:
- The antiinflammatory activity of IgG: the intravenous IgG paradoxThe Journal of Experimental Medicine, 2007
- High-Dose Intravenous Immunoglobulins: An Option in the Treatment of Systemic Lupus ErythematosusHuman Immunology, 2005
- Temporarily controlled HIV-1 replication after intravenous immunoglobulin treatment of Guillain-Barré syndromeScandinavian Journal of Infectious Diseases, 2005
- Partitioning of TSE infectivity during ethanol fractionation of human plasmaBiologicals, 2004
- Immunomodulatory action of intravenous immunoglobulinImmunology, 2002
- Cryoglobulinaemic vasculitis caused by intravenous immunoglobulin treatmentNephrology Dialysis Transplantation, 2001
- High-Dose Intravenous Immunoglobulin Treatment Activates Complement In VivoScandinavian Journal of Immunology, 1998
- Immunoglobulin prevents complement-mediated hyperacute rejection in swine-to-primate xenotransplantation.Journal of Clinical Investigation, 1995
- INTRAVENOUS IMMUNOGLOBULIN SUPPRESSION OF HLA ALLOANTIBODY IN HIGHLY SENSITIZED TRANSPLANT CANDIDATES AND TRANSPLANTATION WITH A HISTOINCOMPATIBLE ORGANTransplantation, 1994
- Transient Reversal of Thrombocytopenia in Idiopathic Thrombocytopenic Purpura by High-Dose Intravenous Gamma GlobulinNew England Journal of Medicine, 1982